If you have been reading about Cardarine and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-11-03. Where a claim depends on a specific study, the study is described rather than over-claimed.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Also called GW501516 and endurobol. |
| Chemical formula | C21H18F3NO3S2 | Molecular weight about 453.5 g/mol. |
| Appearance | White to off-white solid | Form depends on synthesis and purity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, protected from light | Common for research chemicals. |
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
=== International organizations === United Nations: UN Secretary General Antonio Guterres said Gaza was an integral part of a future Palestinian state. Amnesty International's Agnès Callamard condemned Trump's plan to take over Gaza and forcibly relocate Palestinians, calling it "outrageous and shameful." She said it would be a war crime and urged the global community to reject it and uphold Palestinian rights. International Coordination of Revolutionary Parties and Organizations: The ICOR released a statement condemning Trump's Gaza plan saying that it would be tantamount to a new Nakba. Holy See: The Catholic Patriarch of Jerusalem, Pierbattista Pizzaballa, on July 21, 2025, stated that the majority in Gaza will remain there: “First of all, they don’t know where to go, but they also don’t want to leave, because their roots are there, their home is there—or rather, they had their home there—and they want to rebuild it there. The Pope has been very clear on this: no population transfers; there will be no 'rivieras' in Gaza”.
=== Vertebrates === The size of the heart varies among the different animal groups, with hearts in vertebrates ranging from those of the smallest mice (12 mg) to the blue whale (600 kg). In vertebrates, the heart lies in the middle of the ventral part of the body, surrounded by a pericardium. which in some fish may be connected to the peritoneum. In all vertebrates, the heart has an asymmetric orientation, almost always on the left side. According to one theory, this is caused by a developmental axial twist in the early embryo. The sinoatrial node is found in all amniotes but not in more primitive vertebrates. In these animals, the muscles of the heart are relatively continuous, and the sinus venosus coordinates the beat, which passes in a wave through the remaining chambers. Since the sinus venosus is incorporated into the right atrium in amniotes, it is likely homologous with the SA node. In teleosts, with their vestigial sinus venosus, the main centre of coordination is, instead, in the atrium. The rate of heartbeat varies enormously between different species, ranging from around 20 beats per minute in codfish to around 600 in hummingbirds and up to 1,200 bpm in the ruby-throated hummingbird.
=== Endogenous antigens === Endogenous antigens are generated within normal cells as a result of normal cell metabolism, or because of viral or intracellular bacterial infection. The fragments are then presented on the cell surface in the complex with MHC class I molecules. If activated cytotoxic CD8+ T cells recognize them, the T cells secrete various toxins that cause the lysis or apoptosis of the infected cell. In order to keep the cytotoxic cells from killing cells just for presenting self-proteins, the cytotoxic cells (self-reactive T cells) are deleted as a result of tolerance (negative selection). Endogenous antigens include xenogenic (heterologous), autologous and idiotypic or allogenic (homologous) antigens. Sometimes antigens are part of the host itself in an autoimmune disease.
In 1999 its parent company reorganized and changed its name to PE Corporation, and the PE Biosystems Group (formerly again became publicly traded, as a tracking stock of its parent, along with its sister tracking stock company, Celera Genomics. In 2000 the parent became Applera Corporation. The Applied Biosystems name also returned that year, in the name change of the tracking stock from PE Biosystems Group to Applera Corporation-Applied Biosystems Group, an S&P 500 company, which remains as a publicly traded operating group within Applera Corp., along with its sibling operating group, Applera Corporation-Celera Group. Applera derives its name from the combination of its two component groups' names, Appl(iedCel)era In November 2008, a merger between Applied Biosystems and Invitrogen was finalized "creating a global leader in biotechnology reagents and systems". The new company was called Life Technologies.
=== Mechanism of action === Zalcitabine is an analog of pyrimidine. It is a derivative of the naturally existing deoxycytidine, made by replacing the hydroxyl group in position 3' with a hydrogen. It is phosphorylated in T cells and other HIV target cells into its active triphosphate form, ddCTP. This active metabolite works as a substrate for HIV reverse transcriptase, and also by incorporation into the viral DNA, hence terminating the chain elongation due to the missing hydroxyl group. Apart from inhibiting retroviral reverse transcriptase, ddC inhibits mitochondrial DNA polymerase gamma, resulting in a dose-limiting toxicity.
Sources: en.wikipedia.org
== Definitions == Three main types of rectal prolapse are usually identified. These are external rectal prolapse (full thickness / complete rectal prolapse), internal rectal prolapse, and rectal mucosal prolapse. There are several different synonymous terms for IRP, and it has no universally accepted definition. Internal rectal prolapse (IRP) is a telescopic, funnel-shaped invagination (infolding) of the rectal wall that occurs during defecation. The prolapsed segment of rectal wall remains confined within the rectum or the anal canal and is not visible externally (i.e., proximal to the anus). IRP may be a circumferential infolding (involving the full circumference of the rectal wall) or unilateral infolding (involving only one side of the circumference). Usually IRP is defined as a full thickness prolapse of the rectal wall (i.e., involving all three layers). However, sometimes IRP is defined as involving the full thickness of the rectal wall or only part of it. Many synonyms for IRP include the term intussusception. When used unqualified, the term intussusception (or intestinal intussusception) refers to telescopic infolding of a section of the wall of the intestine into the portion directly in front. This is sometimes conceptualized as pulling a sock partially inside out, creating a tube within a tube. The part that moves into the other is called the intussusceptum, and the part that receives it is called the intussuscipiens. This condition usually occurs in the small intestine in children. It less commonly happens in the colon or in adults.
== Career == Akagha attended Southern Methodist University in Dallas, Texas, where she majored in theatre. In the early 2010s, she acted in theatrical productions in California. In 2010, she played Tiger Lily in the Pacific Conservatory of the Performing Arts's production of Peter Pan. In 2011, she acted alongside Brendan Cataldo in Leo Cortez's play, Acting Out, at the Alisal Center for the Fine Arts. In 2012, Akagha began playing the leads in various short films and making guest appearances in television series. She appeared in one-off episodes in the series Men at Work, Nashville and 2 Broke Girls. Akagha started voice acting in video games around 2016, first voicing the character "Plastic" in the game Mirror's Edge: Catalyst. In 2017, she was a voice actor for Wolfenstein II: The New Colossus, in which she provided voices for characters Barbara Casey, Zena Woodard, and Angela Cummings. In 2018, she began appearing in Marvel's Runaways television series as Tamar, a recurring, supporting role. She provided the voice for the superheroine Bumblebee in the animated series Teen Titans Go!. Bumblebee initially appeared in the show's fifth season in the episode "Forest Pirates", which aired in 2019. Akagha voiced the main character, Alyx Vance, in the virtual reality game Half-Life: Alyx. The character was first introduced in the game Half-Life 2 in 2004, being originally played by Merle Dandridge. A new actor was chosen for Alyx Vance partially due to the character's younger age and the "time gap" between this and the previous game.
There were no reports of cross-border operations from either of the ethnic militant groups, although Iran had engaged in attacks against both of them, reportedly killing both Kurdish fighters of the Coalition of Political Forces of Iranian Kurdistan and Baloch fighters of the People's Fighters Front originating from outside Iran. Analysis of satellite images by The Washington Post revealed damage to at least 228 structures or pieces of equipment at US bases across the Persian Gulf, far more than the Trump administration has admitted to. On 1 March, six US soldiers were killed amid more than 30 injured in an Iranian drone attack near Camp Arifjan in Port Shuaiba, Kuwait. Those killed were soldiers of the United States Army Reserve assigned to the 103rd Expeditionary Sustainment Command, headquartered in Des Moines, Iowa. On 8 March, CENTCOM reported that a National Guard soldier died during a medical emergency. A soldier of the 1st Space Brigade was wounded in an attack against Prince Sultan Air Base on 1 March and died from his injuries on 9 March. According to a May report by the Congressional Research Service, 42 U.S. military aircraft were destroyed or damaged during the Iran-U.S. conflict. Data from the Center for Strategic and International Studies (CSIS) indicates that about 65 percent of the 2,330 US Patriot interceptor missiles available at the beginning of the conflict with Iran were used between February and July, leaving less than 850 missiles remaining.
=== Beginnings === As of 1969, the Escadrille Nationale Tchadienne was equipped with five Douglas C-47 cargo aircraft and three Max Holste MH.1521 Broussard liaison aircraft. Most of them were operated by French crews, because there were very few native pilots. In the mid-1970s, it was reinforced by six AD-4N Skyraiders, as well as some additional C-47 and Douglas C-54 transports, the total number of which reached 13 by that time. All of these were donated by France, and most were still crewed by the French. Three Reims-Cessna FTB337s were also delivered in 1977.
ABPP can be analyzed using several complementary detection strategies, each suited to different experimental contexts. These methods generally visualize or enrich the enzyme-probe adduct, enabling qualitative assessment, quantitative comparison, or protein identification by mass spectrometry. One of the earliest and most widely used ABPP workflows employs direct visualization on SDS-PAGE gels. Probes with fluorescent reporter tags (e.g. rhodamine) generate distinct bands corresponding to labeled enzymes, allowing rapid assessment of activity across samples or treatment conditions. This approach is commonly used for broad enzyme families such as serine hydrolases or cysteine proteases and is compatible with high-throughput screening for inhibitors. Because the readout is based on in-gel fluorescence rather than protein abundance, gel-based ABPP readily distinguishes active from inactive enzyme species. However, a significant limitation of gel-based detection is lack of resolving ability, preventing the resolution and identification of low-abundance proteins. In recent years ABPP has been combined with tandem mass spectrometry enabling the identification of hundreds of active enzymes from a single sample. This technique, known as ABPP-MudPIT (multidimensional protein identification technology) is especially useful for profiling inhibitor selectivity as the potency of an inhibitor can be tested against hundreds of targets simultaneously. For proteome-wide analysis, ABPs incorporating affinity tags (e.g.
Sources: en.wikipedia.org
Korolev was buoyed by the first successful launches of the R-7 rocket in August and September, which paved the way for the launch of Sputnik 1. Word came that the US was planning to announce a major breakthrough at an International Geophysical Year conference at the National Academy of Sciences in Washington D.C., with a paper titled "Satellite Over the Planet", on October 6, 1957. Korolev anticipated that von Braun might launch a Jupiter-C with a satellite payload on or around October 4 or 5, in conjunction with the paper. He hastened the launch, moving it to October 4. The launch vehicle for PS-1 was a modified R-7 – vehicle 8K71PS number M1-PS – without much of the test equipment and radio gear that was present in the previous launches. It arrived at the Soviet missile base Tyura-Tam in September and was prepared for its mission at launch site number one. The first launch took place on Friday, October 4, 1957, at exactly 10:28:34 pm Moscow time, with the R-7 and the now named Sputnik 1 satellite lifting off the launch pad and placing the artificial "moon" into an orbit a few minutes later. This "fellow traveler", as the name is translated in English, was a small, beeping ball, less than two feet in diameter and weighing less than 200 pounds. But the celebrations were muted at the launch control center until the down-range far east tracking station at Kamchatka received the first distinctive beep ... beep ... beep sounds from Sputnik 1's radio transmitters, indicating that it was on its way to completing its first orbit.
===== Replacement ===== Some ingredients originating from endangered or otherwise rare species have widely (but not universally) recognized alternatives. For example, rhinoceros horn is generally replaced with a buffalo horn "concentrate powder", a practice adopted by the Chinese Pharmacopoeia. Tiger bone has been replaced with a mixture of bone powders from three livestock species in a Chinese patent medicine approved as a prescription drug in China. More
Lingual antimicrobial peptide (LAP) is a beta-defensin found in bovine internal epithelial tissue, in particular, that of the digestive tract. It has antimicrobial activity against many different pathogens. It was first isolated from an inflamed cattle tongue, hence its designation as lingual. Since then it has been found more extensively throughout the body; its presence has even been detected in bovine milk. Its expression is selective and increases in inflamed areas. LAP may have a closer relationship with immune response than simple antimicrobial activity, such as an association with growth factor activity.
Medical reports describing individuals affected by FOP date back to Dr. Guy Patin in 1648. FOP was originally called myositis ossificans progressiva and was thought to be caused by muscular inflammation (myositis) that caused bone formation. In 1736, London surgeon, John Freke wrote the first case report of FOP, describing a 14-year-old boy that exhibited "'many large swellings on his back, that arise from all the vertebrae of the neck and reach down to the os sacrum. They likewise arise from every rib of his body, and joining together in all parts of his back, as the ramifications of coral do, they make, as it were, a fixed bony pair of bodice." The disease was renamed by Victor A. McKusick in 1970 following the discovery that soft tissue other than muscles (e.g. ligaments) were also affected by the disease process. The best known FOP case is that of Harry Eastlack (1933–1973). His condition began to develop at the age of ten, and by the time of his death from pneumonia in November 1973, six days before his 40th birthday, his body had completely ossified, leaving him able to move only his lips. Eastlack never met another person with FOP during his lifetime. Eastlack donated his body to science and his skeleton is now at the Mütter Museum in Philadelphia, and has proven to be an invaluable source of information in the study of FOP. Another person with FOP, Carol Orzel (April 20, 1959 – February 2018), also donated her body to the museum. Her skeleton was placed on exhibit there, adjacent to Eastlack's, in February 2019.
Sources: en.wikipedia.org
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.
It activates PPARδ, a nuclear receptor that influences gene expression related to lipid and energy metabolism. Animal studies show changes in endurance and lipid levels. Human effects and risks are not well established.
No, cardarine is not a steroid. It belongs to a different chemical class, the PPARδ agonists. It is also not a selective androgen receptor modulator.
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.